ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 78 filers reported holding ENZO BIOCHEM INC in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $138,000 | +15.0% | 39,041 | +3.1% | 0.01% | +33.3% |
Q2 2021 | $120,000 | -9.1% | 37,878 | -1.1% | 0.01% | -25.0% |
Q1 2021 | $132,000 | +34.7% | 38,306 | -2.0% | 0.01% | +14.3% |
Q4 2020 | $98,000 | -22.8% | 39,086 | -34.9% | 0.01% | +75.0% |
Q3 2020 | $127,000 | -42.0% | 60,047 | -38.6% | 0.00% | -33.3% |
Q2 2020 | $219,000 | +73.8% | 97,742 | +95.7% | 0.01% | +100.0% |
Q1 2020 | $126,000 | +5.9% | 49,952 | +9.9% | 0.00% | +50.0% |
Q4 2019 | $119,000 | -33.5% | 45,432 | -8.4% | 0.00% | 0.0% |
Q3 2019 | $179,000 | – | 49,605 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |